MSI Consultancy has announced the promotion of Michael Craig and Dan Heapy to associate partner status, with each set to focus on specific key accounts.
This change to the PR agency's organisational structure will see Mr Craig apply his expertise in orphan and rare disease marketing, while Mr Heapy will specialise in brand strategy and market insight-driven planning, reports Pharmafile.
Mr Craig will bring more than 11 years of industry experience to his new role, having previously applied his skills to consultancy, sales, marketing and government liaison functions.
He has supported commercial teams on more than 20 separate orphan-indicated brands since becoming a consultant and is familiar with segmentation, brand revitalisation, competitive evaluation, strategic planning and marketing training.
Meanwhile, Mr Heapy also possesses more than a decade's worth of pharmaceutical sector experience, having worked at companies such as GlaxoSmithKline, AstraZeneca, Schering-Plough and Merck Sharp and Dohme.
Many of these organisations are now clients of MSI Consultancy, alongside other internationally-renowned names such as Roche, Pfizer, Novartis and Johnson and Johnson.See all the latest jobs in Healthcare Communications